Schedule 13D ownership disclosure
MYnd Analytics, Inc.
Security class unavailable · CUSIP: 62857N202
Event date: 2018-11-26
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 18.9100%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001615774-18-013672
- Form type
- SC 13D
- Filer
- Emmaus Life Sciences, Inc.
- CIK
- CIK 822370
- Filed
- Nov 30, 2018
- Reporting period
- Nov 26, 2018
- Description
- Schedule 13D beneficial ownership